Xometry Inc
3 nominees · 3 ballot items.
Election of three Class II directors; advisory (non-binding) approval of named executive officer compensation (say-on-pay); and ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2026.
Follow how the vote landed and what changed on Xometry Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Class II Directors (Roy Azevedo, Fabio Rosati and Katharine Weymouth
ManagementBoard: FORElect three nominees as Class II directors to serve until the 2029 Annual Meeting.
- 2
Advisory Vote to Approve Executive Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.
More detail
This advisory proposal asks stockholders to approve, on a non-binding basis, the Company’s disclosed compensation of named executive officers (the “say-on-pay” vote). Management seeks shareholder endorsement to validate its executive pay framework, which for 2025 combined base salary, performance-weighted annual cash bonuses tied to revenue and Adjusted EBITDA, time-vesting RSUs, and performance-based RSUs (PSUs) that paid out at 133.95% of target based on 2025 results. The Compensation Committee emphasizes pay-for-performance alignment using peer benchmarking, an independent compensation consultant (Meridian), and a mix of cash and equity to attract, retain and incentivize executives while protecting shareholder interests. The board frames this vote as a ratification of its process—targeting median market pay with upside/downsides linked to corporate metrics—and intends to consider the outcome when making future decisions. The vote is non-binding, so even if approved it does not legally compel management to maintain the exact program, but a negative result could trigger substantive changes and further engagement. Company-specific context includes strong 2025 operational performance (26% revenue growth, improved Adjusted EBITDA and margin expansion), the recent CEO succession plan (effective July 1, 2026) and substantial PSU/RSU awards used to support retention during transition. Management argues the 2025 compensation outcomes reflect measured reward for improved financial performance, while critics could point to the absolute level of equity grants and severance/change-in-control protections as potential governance concerns. The board recommends a FOR vote, citing rigorous peer analysis, use of independent advisors, and the demonstrated link between awarded compensation and company financial targets as justification. Given the advisory nature, the board commits to taking stockholder feedback into account when setting future pay policies and maintaining disclosure transparency.
- 3
Ratification of Selection of Deloitte & Touche LLP as Independent Registered Public Accounting Firm for 2026
ManagementBoard: FORRatify the Audit Committee’s selection of Deloitte & Touche LLP as the company’s independent registered public accounting firm for fiscal year 2026.
Nominees on the ballot3
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | PRIMECAP MANAGEMENT CO/CA/ | 12.3% | 6,495,497 | $265M |
| 2 | EVENTIDE ASSET MANAGEMENT, LLC | 5.6% | 2,960,239 | $121M |
| 3 | FMR LLC | 5.4% | 2,837,525 | $116M |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.8% | 1,983,096 | $81M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 1,980,754 | $81M |
| 6 | AMERIPRISE FINANCIAL INC | 3.3% | 1,716,148 | $70M |
| 7 | BlackRock, Inc. | 3.0% | 1,591,456 | $65M |
| 8 | FIRST TRUST ADVISORS LP | 3.0% | 1,575,201 | $64M |
| 9 | DRIEHAUS CAPITAL MANAGEMENT LLC | 2.9% | 1,512,855 | $62M |
| 10 | BlackRock, Inc. | 2.6% | 1,342,505 | $55M |
Other Industrials sector meetings6
Upcoming shareholder meetings at Xometry Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Xometry Inc 2026 annual meeting?
- Xometry Inc (XMTR) holds its 2026 annual shareholder meeting on Tuesday, June 16, 2026.
- What is the record date for the Xometry Inc 2026 meeting?
- The record date for the Xometry Inc 2026 meeting is Monday, April 20, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Xometry Inc's 2026 meeting?
- The board is presenting 3 director nominees at the Xometry Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Xometry Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Xometry Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.